Outcomes of the Holmium Laser Enucleation of the Prostate for Patients With Prior Benign Prostatic Hyperplasia Surgery = Outcomes ofOutcomes of the Holmium Laser Enucleation of the Prostate for Patients With Prior Benign Prostatic Hyperplasia Surgery the Holmium Laser Enucleation of the Prostate for Patients With Prior Benign Prostatic Hyperplasia Surgery

다국어 초록 (Multilingual Abstract)

Background: To assess the functional outcomes and morbidity in patients undergoing holmium laser enucleation of the prostate (HoLEP) with and without previous transurethral prostate surgery.
Methods: Patients were stratified into two groups, 558 patients who underwent primary HoLEP (group I) and 50 patients who underwent ‘secondary-HoLEP’ with prior transurethral prostate surgery (group II).
Results: There were no significant differences in the preoperative parameters (median age, International Prostate Symptom Score [IPSS], prostate-specific antigen [PSA], prostate volume, maximum urinary flow rate [Qmax], and postvoid residual urine volume [PVR]). No significant intraoperative differences were noted in the use of total energy, resected volume, enucleation time, resection efficiency, and mean catheterization time. There were significant improvements in Qmax, PVR, and IPSS in both groups. Complications in groups I and II included 19 (3.1%) and 1 (2.0%) bladder injuries, 25 (4.4%) and 2 (4.0%) recatheterization for transient voiding difficulty, 20 (3.5%) and 2 (4%) cases of severe hematuria requiring additional treatment, and 5 (0.8%) and 0 cases for remorcellation due to remaining adenoma. Transient incontinence was the most common complication for both groups I and II, 30 cases (5.4%) and 3 cases (6.0%)respectively. Urinary tract infection showed improvement subsequent to antibiotic treatment. During the 6 month follow-up period, urethral stricture occurred in 7 cases (1.3%) for group I and in 1 case (2.0%) for group II.
Conclusion: There were no significant differences in functional outcomes and morbidity between the two groups. ‘Secondary-HoLEP’ seems to be effective and safe for patients with prior BPH surgery.

참고문헌 (Reference)

• 1 박진우, "자발적 복막 내 방광파열에 의한 요성 복수로 유발된 복막염 1례" 대한노인병학회 15 (15): 230-233, 2011
• 2 Kuntz RM., "Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm. : a randomized prospective trial of 120 patients" 168 (168): 1465-1469, 2002
• 3 Lourenco T., "Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement" 12 (12): 515-, 2008
• 4 Shah HN., "Peri-operative complications of holmium laser enucleation of the prostate : experience in the first 280 patients, and a review of literature" 100 : 94-101, 2007
• 5 Tan A., "Meta-analysis of holmium laser enucleation ve rsus transurethral resection of the prostate for symptomatic prostatic obstruction" 94 : 1201-1208, 2007
• 6 Gilling PJ., "Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate : results at 7 years" 109 : 408-411, 2012
• 7 Gilling PJ., "Holmium laser prostatectomy : a technique in evolution" 8 : 11-15, 1998
• 8 Elzayat EA., "Holmium laser enucleation of the prostate: a size-independent new “gold standard”" 66 (66): 108-113, 2005
• 9 Humphreys MR., "Holmium laser enucleation of the prostate--outcomes independent of prostate size?" 180 : 2431-2435, 2008
• 10 Kuntz RM., "Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams : 5-year follow-up results of a randomised clinical trial" 53 : 160-166, 2008
• 11 Naspro R., "Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g : 24-month follow-up" 50 : 563-568, 2006
• 12 Matlaga BR., "Holmium laser enucleation of the prostate for prostates of >125 mL" 97 : 81-84, 2006
• 13 Jaeger CD., "Holmium laser enucleation of the prostate for persistent lower urinary tract symptoms after prior benign prostatic hyperplasia surgery" 81 : 1025-1029, 2013
• 14 Peterson MD., "Holmium laser enucleation of the prostate for men with urinary retention" 174 : 998-1001, 2005
• 15 Hochreiter WW., "Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique" 168 (168): 1470-1474, 2002
• 16 Gilling PJ., "Holmium laser enucleation of the prostate : results at 6 years" 53 : 744-749, 2008
• 17 Kuo RL., "Holmium laser enucleation of the prostate : morbidity in a series of 206 patients" 62 : 59-63, 2003
• 18 Placer J., "Holmium laser enucleation of prostate : outcome and complications of self-taught learning curve" 73 : 1042-1048, 2009
• 19 Seki N., "Holmium laser enucleation for prostatic adenoma : analysis of learning curve over the course of 70 consecutive cases" 170 : 1847-1850, 2003
• 20 Moody JA., "Holmium laser enucleation for prostate adenoma greater than 100 gm. : comparison to open prostatectomy" 165 : 459-462, 2001
• 21 Su Hyung Lee, "Holmium Laser Enucleation of the Prostate: Modified Morcellation Technique and Results" 대한비뇨기과학회 53 (53): 779-784, 2012
• 22 Kuo RL., "Holmium Laser Enucleation of the Prostate(HoLEP) : a technical update" 1 : 6-, 2003
• 23 Elshal AM., "Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH)" 110 (110): E845-E850, 2012
• 24 Elzayat E., "Experience of 603 cases treated with holmium laser enucleation of the prostate(HoLEP)for symptomatic benign prostatic hyperplasia" 175 : 490-, 2006
• 25 Elliott S., "Comparative effectiveness of surgical therapies for benign prostatic hyperplasia" 187 (187): e28-e29, 2012
• 26 Lourenco T., "Alternative approaches to endoscopic ablation for benign enlargement of the prostate : systematic review of randomised controlled trials" 337 : a449-, 2008
• 27 Tan AH., "A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams)" 170 (170): 1270-1274, 2003